Kay Yow Cancer Fund awards $100,000 Women's Cancer Research Grant to Indiana's Simon Cancer Center
Indianapolis, IN – The Kay Yow Cancer Fund® has awarded a $100,000 women’s cancer research grant to the Indiana University Melvin and Bren Simon Cancer Center.
Since 2009, the Kay Yow Cancer Fund has supported a women’s cancer research grant at an institution based in the host city of the annual NCAA Women’s Final Four®. This year’s grant is awarded to the IU Simon Cancer Center in Indianapolis, Indiana, host of the 2016 Women’s Final Four®.
“We are thrilled to receive this grant from the Kay Yow Cancer Fund,” said Patrick Loehrer Sr., M.D., director of the IU Simon Cancer Center. “The researchers and physicians at the IU Simon Cancer Center tackle breast, uterine, vaginal, and ovarian cancers, which affect too many women and their loved ones. These funds will be used by our scientists, enabling them to find better ways to prevent, detect, and treat women’s cancers.”
Before her death, Coach Yow invited the Women’s Basketball Coaches Association (WBCA) and The V Foundation for Cancer Research to partner with her to found the Kay Yow Cancer Fund, a 501 (c)(3) charitable organization committed to being a part of finding an answer in the fight against women’s cancers through raising funds for scientific research, assisting the underserved and unifying people for a common cause.
“Coach Yow was very specific in her direction that the Kay Yow Cancer Fund support research to enhance the quality of life of those individuals battling cancer and to help find a cure,” said Stephanie Glance, Executive Director of the Kay Yow Cancer Fund. “This research grant will continue the legacy of Coach Yow and the Fund’s mission of supporting women’s cancer research.”
The Kay Yow Cancer Fund is privileged to work in collaboration with The V Foundation Scientific Advisory Committee to identify and review grant proposals supporting women’s cancer research. To date, the Kay Yow Cancer Fund has allocated more than $5.28 million in support of women’s cancer research and serving the underserved.